Walk into one hospital for an MRI of your knee and the bill might read $400. Walk into another hospital across town, perhaps owned by the same health system, and the same scan could cost $4,000. Both facilities use similar machines. Both employ qualified radiologists. The image produced is functionally identical.

This is not a quirk. It is a defining feature of the American healthcare market, and it persists for procedures ranging from colonoscopies to cesarean sections to joint replacements. The price variation within a single metropolitan area often exceeds the variation between countries.

Understanding why these differences exist matters because they reveal something fundamental about how healthcare markets actually function—or fail to. Prices in healthcare are not set by supply and demand in any conventional sense. They emerge from a tangle of negotiations, market structures, and information asymmetries that bear little resemblance to the textbook economics most of us learned.

Hospital prices are not posted on a menu. They are negotiated, privately and individually, between each hospital system and each commercial insurer. The result is that a single hospital may charge ten different prices for the same procedure depending on which insurance card you present at the front desk.

What determines those negotiated rates is leverage. When a hospital system controls a large share of a regional market—or operates the only trauma center, the only NICU, the only academic medical center—insurers cannot credibly threaten to exclude it from their networks. Members would revolt. Employers would switch carriers. So the insurer pays what the hospital demands.

Studies from the Health Care Cost Institute and researchers like Zack Cooper have documented this dynamic in detail. Hospitals operating in concentrated markets command prices roughly 12 to 26 percent higher than those facing genuine competition. Mergers between previously competing hospitals consistently raise prices, often without measurable improvements in quality or efficiency.

The consequence is a system where price reflects bargaining position more than cost, quality, or value. A standalone community hospital with weak leverage may accept rates close to what Medicare pays. A flagship system with must-have status can command two or three times that. Same procedure, same city, dramatically different price.

Takeaway

In healthcare, price often signals market power rather than value. The most expensive hospital is not necessarily the best—it may simply be the one insurers cannot afford to exclude.

When researchers actually pull the data, the variation is startling. A 2019 RAND analysis found that prices for identical inpatient services at hospitals within the same metropolitan area routinely vary by factors of three to five. For outpatient procedures, the spread can be even wider.

Consider a knee MRI in the Boston area. Documented prices range from under $500 at independent imaging centers to over $5,000 at academic medical centers, with no meaningful difference in clinical output. A vaginal delivery in San Francisco might cost $8,000 at one hospital and $30,000 at another a few miles away. Colonoscopies, cataract surgeries, joint replacements—the pattern repeats across nearly every shoppable service.

This dispersion is not explained by quality differences. When researchers control for outcomes, complications, patient mix, and facility characteristics, most of the variation remains unexplained by anything a patient would care about. The expensive hospital is not safer. The cheap one is not cutting corners.

What makes this particularly striking is that the variation within cities often exceeds the variation between entire health systems internationally. The price gap between two American hospitals on the same street can be larger than the gap between an average American hospital and an average German one.

Takeaway

Price dispersion in healthcare is so extreme that geography within a single city matters more than national borders. The market is not one market—it is hundreds of opaque micro-markets stacked on top of each other.

If prices vary this dramatically, why don't patients flee the expensive hospitals for the cheap ones? The straightforward answer is that the conditions required for shopping—comparable information, meaningful choice, and direct financial stakes—rarely exist in healthcare simultaneously.

Most patients cannot find prices before service. Federal price transparency rules now require hospitals to publish negotiated rates, but the files are often unwieldy, inconsistently formatted, and difficult to translate into the actual out-of-pocket cost a specific patient will face. Even when prices are technically available, they are buried under codes, modifiers, and bundling rules that defeat casual interpretation.

There is also the matter of clinical urgency and trust. People do not comparison-shop during a cardiac event. They go where the ambulance takes them, or where their physician refers them, or where their insurance steers them. For non-emergency care, the referring doctor often determines the facility, and physicians rarely know prices either.

Finally, insurance dulls the incentive. Once a patient has hit their deductible, the marginal cost of a more expensive hospital is zero to them, even if it is significant to their employer or the broader risk pool. Studies of high-deductible plans suggest that even when patients have skin in the game, fewer than 5 percent meaningfully shop for care.

Takeaway

Markets require informed buyers making consequential choices. Healthcare violates these conditions so thoroughly that the word 'shopping' may simply not apply—and reforms that assume otherwise tend to disappoint.

Healthcare price variation within cities is not a glitch awaiting a technical fix. It reflects the structural reality of a market where prices are negotiated rather than posted, where market power often trumps value, and where the conditions for consumer choice are largely absent.

Policy responses—price transparency mandates, reference pricing, antitrust enforcement, all-payer rate setting—each address pieces of the problem. None alone resolves it. The deeper question is whether we expect healthcare to behave like a market at all, and if not, what alternative arrangements we are willing to accept.

The next time you see a medical bill, it is worth remembering: the number you are looking at says less about the care you received than about the negotiating table you never saw.